BLEEDING-RELATED EPISODES (BRE) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) RECEIVING ELTROMBOPAG (EPAG) OR ROMIPLOSTIM (ROMI): REAL WORLD EVIDENCE FROM 26 US INSTITUTIONS

Forsythe, A; Roy, A; Bhor, M; Portella, MSO

VALUE IN HEALTH, 2017; 20 (9): A545